PortfoliosLab logoPortfoliosLab logo
XPH vs. SPYD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XPH vs. SPYD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XPH achieves a 22.08% return, which is significantly higher than SPYD's 17.73% return. Over the past 10 years, XPH has underperformed SPYD with an annualized return of 4.80%, while SPYD has yielded a comparatively higher 8.80% annualized return.


XPH

1D
0.25%
1M
1.59%
6M
19.87%
YTD
22.08%
1Y
64.62%
3Y*
17.93%
5Y*
7.45%
10Y*
4.80%
ALL TIME*
9.39%

SPYD

1D
0.67%
1M
2.91%
6M
12.53%
YTD
17.73%
1Y
22.89%
3Y*
14.57%
5Y*
9.67%
10Y*
8.80%
ALL TIME*
9.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$49.71M$46.69M$54.64M
$7.06M$7.70M$5.53M

XPH vs. SPYD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XPH
SPDR S&P Pharmaceuticals ETF
22.08%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%
SPYD
State Street SPDR Portfolio S&P 500 High Dividend ETF
17.73%4.65%15.34%3.91%-1.17%32.73%-11.64%21.20%-4.89%12.67%

Correlation

The correlation between XPH and SPYD is 0.31, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.31

Correlation (3Y)
Balances recent behavior with more history.

0.51

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.53

Correlation (10Y)
Provides a long-term view across more market conditions.

0.52

Correlation (All Time)
Calculated using the full available price history since Oct 22, 2015

0.50

The correlation between XPH and SPYD shifts across timeframes, from 0.31 (1 year) to 0.53 (5 years), reflecting how their relationship changes across market environments.

XPH vs. SPYD - Sectors Allocation Comparison


Sectors
XPH
SPYD

Healthcare

100.0%
5.4%

Basic Materials

-

3.7%

Communication Services

-

4.6%

Consumer Cyclical

-

6.4%

Consumer Defensive

-

14.6%

Energy

-

8.9%

Financial Services

-

12.6%

Industrials

-

2.5%

Real Estate

-

26.5%

Technology

-

2.7%

Utilities

-

11.6%

Healthcare

XPH
100.0%
SPYD
5.4%

Basic Materials

XPH

-

SPYD
3.7%

Communication Services

XPH

-

SPYD
4.6%

Consumer Cyclical

XPH

-

SPYD
6.4%

Consumer Defensive

XPH

-

SPYD
14.6%

Energy

XPH

-

SPYD
8.9%

Financial Services

XPH

-

SPYD
12.6%

Industrials

XPH

-

SPYD
2.5%

Real Estate

XPH

-

SPYD
26.5%

Technology

XPH

-

SPYD
2.7%

Utilities

XPH

-

SPYD
11.6%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XPH vs. SPYD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

XPH
XPH Risk / Return Rank: 9494
Overall Rank
XPH Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 9494
Sortino Ratio Rank
XPH Omega Ratio Rank: 9292
Omega Ratio Rank
XPH Calmar Ratio Rank: 9595
Calmar Ratio Rank
XPH Martin Ratio Rank: 9494
Martin Ratio Rank

SPYD
SPYD Risk / Return Rank: 8181
Overall Rank
SPYD Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
SPYD Sortino Ratio Rank: 8585
Sortino Ratio Rank
SPYD Omega Ratio Rank: 7979
Omega Ratio Rank
SPYD Calmar Ratio Rank: 8585
Calmar Ratio Rank
SPYD Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

XPH vs. SPYD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XPHSPYDDifference
Sharpe ratioReturn per unit of total volatility

+0.94

Sortino ratioReturn per unit of downside risk

+0.88

Omega ratioGain probability vs. loss probability

1.46

1.33

+0.13

Calmar ratioReturn relative to maximum drawdown

5.43

3.26

+2.17

Martin ratioReturn relative to average drawdown

19.31

9.67

+9.64

XPH vs. SPYD - Sharpe Ratio Comparison

The current XPH Sharpe Ratio is 2.88, which is higher than the SPYD Sharpe Ratio of 1.94. The chart below compares the historical Sharpe Ratios of XPH and SPYD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XPH vs. SPYD - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, roughly equal to the maximum SPYD drawdown of -46.42%. Use the drawdown chart below to compare losses from any high point for XPH and SPYD.


Loading charts...

Drawdown Indicators


XPHSPYDDifference

Max Drawdown

Largest peak-to-trough decline

-48.03%

-46.42%

-1.61%

Max Drawdown (1Y)

Largest decline over 1 year

-11.97%

-7.05%

-4.92%

Max Drawdown (3Y)

Largest decline over 3 years

-23.57%

-16.13%

-7.44%

Max Drawdown (5Y)

Largest decline over 5 years

-30.92%

-22.25%

-8.67%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

-46.42%

+10.45%

Current Drawdown

Current decline from peak

-2.60%

-1.40%

-1.20%

Average Drawdown

Average peak-to-trough decline

-17.12%

-6.09%

-11.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.36%

2.37%

+0.99%

Volatility

XPH vs. SPYD - Volatility Comparison

SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.62% compared to State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) at 3.94%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than SPYD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XPHSPYDDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.62%

3.94%

+3.68%

Volatility (6M)

Calculated over the trailing 6-month period

17.53%

8.39%

+9.14%

Volatility (1Y)

Calculated over the trailing 1-year period

22.59%

11.88%

+10.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.02%

15.98%

+5.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.14%

19.77%

+2.37%

XPH vs. SPYD - Expense Ratio Comparison

XPH has a 0.35% expense ratio, which is higher than SPYD's 0.07% expense ratio.


Dividends

XPH vs. SPYD - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.49%, less than SPYD's 4.08% yield.


PositionTTM20252024202320222021202020192018201720162015
SPYD
State Street SPDR Portfolio S&P 500 High Dividend ETF
4.08%4.52%4.31%4.66%5.01%3.68%4.95%4.42%4.75%4.63%4.34%1.13%
XPH
SPDR S&P Pharmaceuticals ETF
0.49%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


XPH and SPYD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XPH has higher volatility (7.62%) compared to SPYD (3.94%). In terms of maximum drawdown, XPH dropped -48.03% vs SPYD's -46.42%.

On 10-year performance, SPYD leads with 8.80% vs 4.80% for XPH. On fees, SPYD is cheaper at 0.07% per year. On volatility, SPYD has been the lower-risk option at 3.94%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SPYD has performed better with a 8.80% return vs 4.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SPYD is cheaper with a 0.07% expense ratio, compared with 0.35% for XPH.

SPYD has the higher dividend yield at 4.08%, compared with 0.49% for XPH.

XPH is categorized as Health & Biotech Equities, while SPYD is S&P 500. XPH tracks S&P Pharmaceuticals Select Industry Index, while SPYD tracks S&P 500 High Dividend Index. Their fees differ too: 0.35% for XPH and 0.07% for SPYD.

XPH currently has the higher Sharpe Ratio (2.88 vs 1.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XPH and SPYD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer